The Nuclear Medicine Market size is expected to grow at an annual average of 4% during 2021-2027. Nuclear medicines are used for diagnostic and therapeutic purposes, and there are more than 30 specific radiopharmaceuticals used by healthcare workers. Nuclear medicines in various forms are useful in the treatment of cancer, diseases of the nervous system, gastrointestinal and other diseases. While not all medical isotopes are particularly radioactive in nature, nuclear medicines or radiopharmaceuticals make one of the most common drugs used to diagnose dysfunction of human tissues. 30 specific radiopharmaceuticals used by healthcare workers.
(Get 15% Discount on Buying this Report)
A full report of Nuclear Medicine Market is available at: https://www.orionmarketreports.com/nuclear-medicine-market/55696/
The following segmentation are covered in this report:
By Type
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
- Brachytherapy Isotopes
By Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
Company Profile
- Triad Isotopes
- Siemens Healthineers AG
- Advanced Accelerator Applications
- Curium
- Cambridge Isotope Laboratories Inc.
- Cardinal Health Inc.
- GE Healthcare
- Nordion Inc.
- Isotec Inc. (Sigma-Aldrich)
- Lantheus Medical Imaging, Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Nuclear Medicine Market
- The market share of the global Nuclear Medicine Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Nuclear Medicine Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Nuclear Medicine Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
